Argos Soditic Acquires Cisbio Bioassays | GenomeWeb
Home » Argos Soditic Acquires Cisbio Bioassays

Argos Soditic Acquires Cisbio Bioassays

Nov 18, 2013
|
a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Private equity group Argos Soditic and management members of Cisbio Bioassays today announced that they have acquired Cisbio Bioassays from IBA for an undisclosed amount.

As a result, Cisbio will operate as an independent company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Jun 15, 2016

Adaptive Biotechnologies, Argos Therapeutics to Collaborate on Patient Response to Immunotherapies

Mar 14, 2016

BabySeq Researcher Presents Initial Findings at ACMG

Jan 27, 2016

Hologic Q1 Revenues Grow 7 Percent

Feb 23, 2016

WuXi NextCode Sequencing Facility Receives CAP Accreditation

May 13, 2016

Infectious Disease Sequencing Dx Devices to Be Regulated by FDA

Jan 27, 2016

Quanterix Inks Distribution Deals in Asia Pacific Region

The Scan

This Week in PLOS

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Even More Data to Mine

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

New Spaces in Connecticut

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Healthier, If Not Longer, Life

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.

What's Popular?

In Cell Biology Research

  1. CRISPR/Cas9 Deployed as Cellular Historian

    Premium

  2. Proteins, Front and Center

    Premium

  3. StemCells to Acquire UK's Stem Cell Sciences for Up to $4.85M to Build Drug-Discovery Play

    Premium

  4. Horizon Inks Screening Deal with SuperGen

  5. Aragen Bioscience Inks License with Cevec

Sponsorships

Privacy Policy.  Copyright © 2016 Genomeweb LLC.  All Rights Reserved.